
Aspo Pharmaceuticals LLP
About Aspo Pharmaceuticals LLP
Data last updated:
Aspo Pharmaceuticals LLP is a limited liability partnership (LLP) based in Baddi, Himachal Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Himachal Pradesh, under LLPIN AAL-1485. Its GSTIN is 02ABKFA2506N1ZM (Himachal Pradesh).
The LLP has a total obligation of contribution of ₹2 Cr. It is led by designated partners including Sanchit Garg and Munish Gupta.
Its latest statement of accounts is for the year ended 31 March 2026. The registered office is at Plot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2026, the LLP reported a revenue of ₹28.11 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹68.11 Lakh (net margin -2.4%) and EBITDA of ₹95.08 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 647% over five years.
The LLP has about 56 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹13.99 Cr on record. Court records list 8 cases involving the LLP, including 5 filed by the LLP and 3 filed against it; 4 cases are pending.
Company details
Recognitions & Rankings of Aspo Pharmaceuticals
Contact details
Aspo Pharmaceuticals LLP's registered office is in Baddi, Himachal Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aspo Pharmaceuticals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aspo Pharmaceuticals LLP
FY 2026 filings availableAspo Pharmaceuticals LLP reported revenue of ₹28.11 Cr (up 1% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 647% over five years, including 1% growth in the latest year. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | ₹28.11 Cr | ||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹68.11 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -2.4% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Aspo Pharmaceuticals LLP, buy the company report.
Designated partners of Aspo Pharmaceuticals LLP
Aspo Pharmaceuticals has 6 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanchit Garg | Designated Partner | 19 Jul 2018 | 8 Years 3 Months | Current |
| Munish Gupta | Designated Partner | 19 Jul 2018 | 8 Years 3 Months | Current |
| Deepak Gupta Also directs: Aspo Healthcare Private Limited | Designated Partner | 19 Jul 2018 | 8 Years 3 Months | Current |
| Vikas Gupta Also directs: Velnex Medicare India Private Limited, Nexa Medic Limited | Designated Partner | 19 Jul 2018 | 8 Years 3 Months | Current |
| Arvind Jindal | Designated Partner | 01 Jun 2021 | 5 Years 5 Months | Current |
| Vivek Jindal Also directs: Kurukshetra Foods Private Limited | Designated Partner | 01 Jun 2021 | 5 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jun 2026 | 101334960 | Punjab National Bank | ₹1.25 Cr | Open | |
| 17 Oct 2025 | 101182003 | Punjab National Bank | ₹18.34 Lakh | Open | |
| 17 Oct 2025 | 101182008 | Punjab National Bank | ₹18.34 Lakh | Open | |
| 18 Jun 2022 | 100631628 | Punjab National Bank | ₹81 Lakh | Open | |
| 11 Nov 2021 | 100495241 | Punjab National Bank | ₹5.68 Lakh | Open |
To see the full charge records of Aspo Pharmaceuticals LLP, buy the company report.
Total charge records: 7 View all charges
Legal cases
Aspo Pharmaceuticals LLP has 8 court cases on record: 5 filed by Aspo Pharmaceuticals, 3 filed against it. 4 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 3 | 3 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Execution petition | Filed by the company against M/S Aronation Life Care Pvt Ltd | Disposed |
| High Court for State of Telangana | Court case (CRLP) | Filed by the company against Union of India | Pending |
| District court, Karimnagar, Telangana | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed against the company by State of Telangana Rep by Drugs Inspector | Pending |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by M/S Hemkund Enterprises | Pending |
To see the full case history of Aspo Pharmaceuticals LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspo Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aspo Pharmaceuticals LLP has a workforce of 56 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 56 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Aspo Pharmaceuticals LLP, buy the company report.
GST
Aspo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02ABKFA2506N1ZM | Himachal Pradesh | Active | 27 Feb 2018 |
To see the full GST registrations and return filing status of Aspo Pharmaceuticals LLP, buy the company report.
Recent activity
Aspo Pharmaceuticals LLP has 9 designated partner changes on record since 2018: 6 appointments and 3 cessations. The latest: Arvind Jindal was appointed as Designated Partner on 01 Jun 2021.
8 earlier events are in the company report.
Frequently asked questions
Aspo Pharmaceuticals is an active limited liability partnership based in Baddi, Himachal Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2017 (9+ years old) and is registered under LLPIN AAL-1485.
Aspo Pharmaceuticals has 6 current designated partners:
- Sanchit Garg - Designated Partner
- Munish Gupta - Designated Partner
- Deepak Gupta - Designated Partner
- Vikas Gupta - Designated Partner
- Arvind Jindal - Designated Partner
- Vivek Jindal - Designated Partner
The latest financial statements of Aspo Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 March 2026. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aspo Pharmaceuticals is 02ABKFA2506N1ZM, registered in Himachal Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Aspo Pharmaceuticals is AAL-1485. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Aspo Pharmaceuticals has 8 court cases on record: 5 filed by the LLP and 3 filed against it. 4 are pending. Most are in the district courts.
Aspo Pharmaceuticals was incorporated on 15 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Arvind Jindal was appointed as Designated Partner on 01 Jun 2021. Vivek Jindal was appointed as Designated Partner on 01 Jun 2021. Amit Garg ceased to be Designated Partner on 23 Aug 2018. Aspo Pharmaceuticals has 9 designated partner changes on record in total.
Yes, Aspo Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Aspo Pharmaceuticals is at Plot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.

